Pharma Power Play: Marksans Marks Q4 with Stellar Profits and Revenue Surge

Unknown Apr 02, 2026 4 Views

Marksans Pharma revealed its consolidated financial performance for the quarter ended March 2025 with a strong increase in operating performance. The company posted consolidated revenue from operations of ₹7.08 billion with evidence of robust demand and good sales momentum in its major markets....

Stay Ahead – Explore Now! KYC Gets a Makeover: SEBI’s New Rules Say ‘Know Your Client, But Know Them Better